Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Plasma Fractionation Market?

The size of the plasma fractionation market has witnessed significant growth in the past years. It is projected to expand from $31.42 billion in 2024 to $34.44 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this growth during the historical period include an increase in hemophilia and immunodeficiency disorders, an aging population, the rise of demand for immunoglobulins, the expansion of plasma collection centers and an increase in the number of surgical procedures.

What Growth Rate Is Forecasted for the Plasma Fractionation Market by 2029?

In the next few years, the market size for plasma fractionation is projected to experience swift expansion, reaching $51.56 billion in 2029 with a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period is expected to be driven by factors such as an increase in worldwide health care spending, a growing use of plasma-derived medical products, a rise in research and development investment, a higher demand for plasma in treating neurological disorders, and the enlargement of plasma fractionation facilities. Other prominent trends for the forecast period include the emergence of new fractionation technologies, a shift towards albumin and immunoglobulin therapies, an increasing demand for specialty plasma products, an emphasis on pathogen inactivation technologies, and strategic alliances and partnerships within the plasma industry.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

Which Key Companies Are Shaping the Future of the Plasma Fractionation Market?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Which Factors Are Driving Demand in the Plasma Fractionation Industry?

The proliferation of chronic diseases is likely to fuel the plasma fractionation market’s expansion. Chronic diseases such as heart disease, cancer, and diabetes, are conditions lasting over a year that necessitate continuous medical care. Utilizing plasma products to treat people with chronic conditions can reduce illness, enhance their quality of life, and offer cost-effectiveness, which will consequently escalate plasma fractionation demand. For instance, the National Library of Medicine, a U.S-based organization, reported in January 2023 that the population of individuals over 50 years old with one or more chronic diseases is predicted to surge by 99.5%, reaching 142.66 million by 2050, a significant jump from 71.522 million in 2020 in the United States. In short, the escalating prevalence of chronic diseases is contributing to the growth of the healthcare analytical testing service market. Therefore, the plasma fractionation market is likely to be driven by the rising number of chronic diseases across all age groups.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

How Is the Plasma Fractionation Market Segmented by Several Divisions?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

What are the Emerging Market Trends Driving the Growth of the Plasma Fractionation Industry?

Top corporations in the marketplace are unveiling novel technologies, such as hi-tech facility processes that convert donated human plasma into vital medicines, employing cutting-edge techniques to amplify efficiency and safety. For instance, in March 2023, a new $470 million plasma fractionation facility was opened by CSL Behring, a German-based firm. The establishment utilizes state-of-the-art technology to increase the effectiveness and safety of plasma processing, guaranteeing superior quality and more dependable medicines. By boosting the supply of these crucial medicines, the facility seeks to address the escalating demand, thereby ensuring more patients can access life-preserving therapies. The risk of contamination is reduced and overall hygiene conditions are improved thanks to advanced automation and self-cleaning systems, which ultimately enhances the safety of patients.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Which Regions Are Driving Growth in the Plasma Fractionation Market?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7543

This Report Delivers Insight On:

1. How big is the plasma fractionation market, and how is it changing globally?

2. Who are the major companies in the plasma fractionation market, and how are they performing?

3. What are the key opportunities and risks in the plasma fractionation market right now?

4. Which products or customer segments are growing the most in the plasma fractionation market?

5. What factors are helping or slowing down the growth of the plasma fractionation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model